Veteran Medtech Executive Joins Tulavi Therapeutics as Vice Chairman of Board of Directors

Strategic Insights -

Veteran medtech executive Raymond W. Cohen has joined Tulavi Therapeutics, a medical device company transforming peripheral nerve surgery with its Adaptive Hydrogel Technology, as Vice Chairman of its Board of Directors. Cohen brings a proven track record of scaling innovative medical device companies and successful exits, including the sale of Axonics, Inc. to Boston Scientific Corporation. He will contribute to the company's growth trajectory, advancing the Adaptive Hydrogel Technology and expanding access to essential peripheral nerve surgery.

Key Takeaways:

  • Raymond W. Cohen, a veteran medtech executive, has joined Tulavi Therapeutics as Vice Chairman of its Board of Directors, bringing a proven track record of scaling innovative medical device companies and successful exits.
  • Cohen co-founded Axonics, Inc. in 2013 and took it public in 2018, ranking No. 1 on the Deloitte Technology Fast 500 and the Financial Times ranking of the fastest-growing companies in the Americas in 2021 and 2022.
  • He was instrumental in the sale of Axonics to Boston Scientific Corporation and the sale of SoniVie, Ltd. to BSX in March 2025.
  • Additionally, Cohen serves on the Board of Directors of Spectrum Vascular, a privately held PE-backed company, and Kestra Medical Technologies, a wearable defibrillator product company.
  • Tulavi Therapeutics' Adaptive Hydrogel Technology represents a breakthrough approach to nerve repair and protection, addressing critical unmet needs in peripheral nerve surgical procedures.
  • The company aims to advance patient outcomes and improve the standard of care for surgeons treating peripheral nerve conditions.

Statistics:

  • Cohen served as CEO and member of the board of directors of Axonics, Inc., a medical device company he co-founded in 2013.
  • Axonics ranked No. 1 on the Deloitte Technology Fast 500 and the Financial Times ranking of the fastest-growing companies in the Americas in 2021 and 2022.
  • Cohen has successfully scaled two medical device companies, Axonics and SoniVie, Ltd., with the latter's sale to BSX in March 2025.
  • Tulavi Therapeutics is a privately held medical device company based in Los Gatos, CA, with a mission to transform peripheral nerve surgery.

Sources:

  • "Tulavi Therapeutics Appoints Raymond W. Cohen to Board of Directors." PRNewswire. June 18, 2025.
  • Axonics, Inc. List of company executives. Retrieved from [https://www.axonics.com/executive-management/](https://www.axonics.com/executive-management/).
  • SoniVie, Ltd. List of company executives. Retrieved from [https://www.sonivie.com/about/team/](https://www.sonivie.com/about/team/).